Compare Suven Life Sciences with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES ALKEM LABORATORIES SUVEN LIFE SCIENCES/
ALKEM LABORATORIES
 
P/E (TTM) x -97.2 23.4 - View Chart
P/BV x 1.5 5.6 27.0% View Chart
Dividend Yield % 1.5 0.9 175.2%  

Financials

 SUVEN LIFE SCIENCES   ALKEM LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
ALKEM LABORATORIES
Mar-20
SUVEN LIFE SCIENCES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3382,720 12.4%   
Low Rs1691,660 10.2%   
Sales per share (Unadj.) Rs52.1697.9 7.5%  
Earnings per share (Unadj.) Rs6.896.1 7.1%  
Cash flow per share (Unadj.) Rs8.6117.3 7.3%  
Dividends per share (Unadj.) Rs1.5025.00 6.0%  
Dividend yield (eoy) %0.61.1 51.8%  
Book value per share (Unadj.) Rs65.3515.2 12.7%  
Shares outstanding (eoy) m127.28119.57 106.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.1 155.0%   
Avg P/E ratio x37.122.8 162.9%  
P/CF ratio (eoy) x29.618.7 158.4%  
Price / Book Value ratio x3.94.3 91.4%  
Dividend payout %22.026.0 84.4%   
Avg Mkt Cap Rs m32,272261,879 12.3%   
No. of employees `0001.114.3 7.6%   
Total wages/salary Rs m66115,055 4.4%   
Avg. sales/employee Rs Th6,132.25,822.6 105.3%   
Avg. wages/employee Rs Th611.11,050.5 58.2%   
Avg. net profit/employee Rs Th803.5802.0 100.2%   
INCOME DATA
Net Sales Rs m6,63583,444 8.0%  
Other income Rs m2421,042 23.2%   
Total revenues Rs m6,87784,486 8.1%   
Gross profit Rs m1,60414,734 10.9%  
Depreciation Rs m2212,528 8.8%   
Interest Rs m38651 5.8%   
Profit before tax Rs m1,58712,598 12.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,105 65.0%   
Profit after tax Rs m86911,493 7.6%  
Gross profit margin %24.217.7 136.9%  
Effective tax rate %45.28.8 515.8%   
Net profit margin %13.113.8 95.1%  
BALANCE SHEET DATA
Current assets Rs m6,23254,960 11.3%   
Current liabilities Rs m1,49032,433 4.6%   
Net working cap to sales %71.527.0 264.7%  
Current ratio x4.21.7 246.8%  
Inventory Days Days8680 108.6%  
Debtors Days Days8372 114.5%  
Net fixed assets Rs m4,04332,710 12.4%   
Share capital Rs m127239 53.2%   
"Free" reserves Rs m8,18361,368 13.3%   
Net worth Rs m8,31061,607 13.5%   
Long term debt Rs m181,592 1.1%   
Total assets Rs m10,38999,433 10.4%  
Interest coverage x43.120.4 211.7%   
Debt to equity ratio x00 8.3%  
Sales to assets ratio x0.60.8 76.1%   
Return on assets %8.712.2 71.5%  
Return on equity %10.518.7 56.1%  
Return on capital %19.521.0 93.1%  
Exports to sales %019.1 0.0%   
Imports to sales %03.0 0.0%   
Exports (fob) Rs mNA15,917 0.0%   
Imports (cif) Rs mNA2,483 0.0%   
Fx inflow Rs m5,62216,061 35.0%   
Fx outflow Rs m1,7992,483 72.5%   
Net fx Rs m3,82213,578 28.2%   
CASH FLOW
From Operations Rs m3565,851 6.1%  
From Investments Rs m-279-7,414 3.8%  
From Financial Activity Rs m-225792 -28.4%  
Net Cashflow Rs m-148-731 20.3%  

Share Holding

Indian Promoters % 63.4 66.9 94.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 0.0 -  
Shareholders   37,287 68,381 54.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA  SANOFI INDIA  

Compare SUVEN LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


May 7, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - DR. DATSONS LABS COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS